Mounjaro
Also known as Mounjaro — this name points to Tirzepatide in our directory.
About Tirzepatide
A dual GIP and GLP-1 receptor agonist with strong weight-loss and glycemic data in trials.
Tirzepatide activates both GLP-1 and GIP receptors—a newer mechanism than semaglutide alone. SURMOUNT trials showed ~20% body weight loss at higher doses. Prescription-only; side effects include nausea and rare pancreatitis risk.
Where you will see Mounjaro
Mounjaro is a prescription drug brand—not a cosmetic INCI name or bulk research powder. The active molecule is Tirzepatide. Dosing, indications, and side effects come from the FDA label and your clinician, not peptide forum stacks.
Compare Tirzepatide
Other names
Mounjaro
Zepbound
Dual GIP/GLP-1 agonist
Common questions
Is Mounjaro the same as Tirzepatide?
Yes. Mounjaro is a brand or nickname that refers to Tirzepatide in our directory—the same active molecule, different packaging or marketing name.
What is Tirzepatide?
A dual GIP and GLP-1 receptor agonist with strong weight-loss and glycemic data in trials. Tirzepatide activates both GLP-1 and GIP receptors—a newer mechanism than semaglutide alone. SURMOUNT trials showed ~20% body weight loss at higher doses. Prescription-only; side effects include nausea and rare pancreatitis risk.
How do I find Mounjaro on a label?
No. Mounjaro is a prescription medicine dispensed through pharmacies with a clinician—not a peptide powder or cosmetic serum you buy by alias alone.